Filed: 2/13/2024ACC: 0000904454-24-000136
📋 What this filing means
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $47.39M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$47.39M
Total AUM (reported)
1.11M
Total Shares
Allocation by class
CL A$41.24M87.0%
COM$4.35M9.2%
SPONSORED ADS$908.9K1.9%
COM CL A$494.7K1.0%
CL B NEW$392.3K0.8%
*W EXP 08/01/2$633.000.0%
Portfolio Concentration
Top 3$44.01M92.9%
4–10$3.11M6.6%
11–25$271.5K0.6%
Top 3 weight
92.9%
Top 10 weight
99.4%
Voting Authority Distribution
Total shares with voting rights: 1.11M
Sole
Full voting authority
1.11M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole13
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings13
Rows:
BERKSHIRE HATHAWAY INC DEL
SOLEShares76.00
TypeSH
Market value$41.24M
87.03%
Sole
76.00
Shared
0.00
None
0.00
RAPT THERAPEUTICS INC
SOLEShares73.38K
TypeSH
Market value$1.82M
3.85%
Sole
73.38K
Shared
0.00
None
0.00
TENAYA THERAPEUTICS INC
SOLEShares291.83K
TypeSH
Market value$945.5K
2.00%
Sole
291.83K
Shared
0.00
None
0.00
KANZHUN LIMITED
SOLEShares54.72K
TypeSH
Market value$908.9K
1.92%
Sole
54.72K
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares192.97K
TypeSH
Market value$652.2K
1.38%
Sole
192.97K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares47.93K
TypeSH
Market value$450.5K
0.95%
Sole
47.93K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares1.10K
TypeSH
Market value$392.3K
0.83%
Sole
1.10K
Shared
0.00
None
0.00
QUANTUMSCAPE CORP
SOLEShares48.46K
TypeSH
Market value$336.8K
0.71%
Sole
48.46K
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares91.91K
TypeSH
Market value$206.8K
0.44%
Sole
91.91K
Shared
0.00
None
0.00
AMPLITUDE INC
SOLEShares12.41K
TypeSH
Market value$157.9K
0.33%
Sole
12.41K
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares249.63K
TypeSH
Market value$137.3K
0.29%
Sole
249.63K
Shared
0.00
None
0.00
PULMONX CORP
SOLEShares10.48K
TypeSH
Market value$133.6K
0.28%
Sole
10.48K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares33.33K
TypeSH
Market value$633.00
<0.01%
Sole
33.33K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BERKSHIRE HATHAWAY INC DELSOLE | CL A | 76.00 | SH | $41.24M 87.03% | 76.00 | 0.00 | 0.00 |
RAPT THERAPEUTICS INCSOLE | COM | 73.38K | SH | $1.82M 3.85% | 73.38K | 0.00 | 0.00 |
TENAYA THERAPEUTICS INCSOLE | COM | 291.83K | SH | $945.5K 2.00% | 291.83K | 0.00 | 0.00 |
KANZHUN LIMITEDSOLE | SPONSORED ADS | 54.72K | SH | $908.9K 1.92% | 54.72K | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 192.97K | SH | $652.2K 1.38% | 192.97K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM | 47.93K | SH | $450.5K 0.95% | 47.93K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 1.10K | SH | $392.3K 0.83% | 1.10K | 0.00 | 0.00 |
QUANTUMSCAPE CORPSOLE | COM CL A | 48.46K | SH | $336.8K 0.71% | 48.46K | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 91.91K | SH | $206.8K 0.44% | 91.91K | 0.00 | 0.00 |
AMPLITUDE INCSOLE | COM CL A | 12.41K | SH | $157.9K 0.33% | 12.41K | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 249.63K | SH | $137.3K 0.29% | 249.63K | 0.00 | 0.00 |
PULMONX CORPSOLE | COM | 10.48K | SH | $133.6K 0.28% | 10.48K | 0.00 | 0.00 |
SURROZEN INCSOLE | *W EXP 08/01/2 | 33.33K | SH | $633.00 <0.01% | 33.33K | 0.00 | 0.00 |